{
    "2020-06-11": [
        [
            {
                "time": "2020-06-11",
                "original_text": "Coronavirus update: US reopening dogged by fears of new wave as pharma presses on with vaccine",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "US",
                        "reopening",
                        "fears",
                        "pharma",
                        "vaccine"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-06-11",
                "original_text": "AbbVie Inks Deal With Genmab, Announces ADC Candidate Data",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Genmab",
                        "ADC",
                        "Candidate",
                        "Data"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-11",
                "original_text": "Regeneron Begins Human Trials of a Potential COVID-19 Treatment",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Human",
                        "Trials",
                        "COVID-19",
                        "Treatment"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-11",
                "original_text": "Company News for Jun 11, 2020",
                "features": {
                    "keywords": [
                        "Company",
                        "News"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-06-11",
                "original_text": "Exclusive: Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist",
                "features": {
                    "keywords": [
                        "Lilly",
                        "COVID-19",
                        "treatment",
                        "authorized",
                        "September",
                        "chief",
                        "scientist"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}